FDA Investigator Colleen F Hoyt
Colleen F Hoyt has inspections in 2 countries as of 09 Dec 2022. Colleen F Hoyt has collaborated with a combinined 1354 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
09 Dec 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Alicia M Mozzachio,
Arlene M Badillo,
Ashley J Burns,
Brooke K Higgins,
Brooke K Seeman,
Carlos A Medina,
Carole L Jones,
CDR Ileana Barreto Pettit,
Charisse K Green,
Denis Gavin, PhD,
Diane T Bargo,
Diane T O'brien,
Dr. Carmelo Rosa,
Edwin Melendez,
Emest F Bizjak,
Erika V Butler,
Feiyan Jin,
Frederick L Fricke,
Ileana Pettit,
Jacqueline Mdiaz Albertini,
Joan Johnson,
Joe X Phillips,
Jonathan W Chapman,
Jorge L Lajara,
Jose A Moreno,
Jose E Melendez, DDC,
Jose R Lopez,
Kimberly L Schultz,
Laurissa S Flowers,
LCDR Anastasia Mpiliafas Brown,
Linda L Ng,
Lori S Lawless,
Marcellinus D Dordunoo,
Marianela Aponte Cruz,
Maribel V Juarbe,
Marie T Falcone,
Marta E Gonzalez,
Melissa J Garcia,
Merideth K Rose,
Michael E Maselli,
Michael R Goga,
Mra Davism,
Myriam M Sosa,
Nerizza B Guerin,
Patrice S Hall,
Patricia A Morrow,
Patrick L Wisor,
Rachel C Harrington,
Rafael Nevarez,
Rafael Nevarez Nieves,
Ramon A Hernandez,
Randa Melhem, PhD,
Rebecca Parrilla,
Rebecca Rodriguez,
Richard L Rutherford,
Russell J Glapion,
Sharmista Chatterjee,
Sharon K Thoma, PharmD,
Shirshendu K Deb, PhD,
Shusheen A Alexander,
Steven B Barber,
Steven D Kehoe,
Steven P Donald,
Susan M Jackson,
Suzanne M Healy,
Suzanne M Muchene,
Tajah L Blackburn,
Thai D Truong,
Thai Truong,
Unnee Ranjan,
Vipulchandr N Dholakia,
William J Leonard,
Xiaobin Lu (Victor), PhD,
Xiaohui Shen
Colleen F Hoyt's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2019 | FDA 483 Response | Novartis Pharmaceuticals Corporation - Form 483R, 2019-09-12 |
August, 2019 | EIR | Novartis Pharmaceuticals Corporation - EIR, 2019-08-21 |
October, 2007 | FDA 483 | Patheon Puerto Rico, Inc. - Form 483, 2007-10-29 |
August, 2019 | FDA 483 | Novartis Pharmaceuticals Corporation - Form 483, 2019-08-21 |
August, 2006 | FDA 483 | Bell-More Labs Inc - Form 483, 2006-08-17 |
October, 2018 | EIR | AGC Biologics, Inc. - EIR, 2019-11-13 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more